Literature DB >> 20507847

Simplifying stroke risk stratification in atrial fibrillation patients: implications of the CHA2DS2-VASc risk stratification scores.

Burak Pamukcu1, Gregory Y H Lip, Deirdre A Lane.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20507847     DOI： 10.1093/ageing/afq059

Source DB:  PubMed          Journal:  Age Ageing        ISSN： 0002-0729            Impact factor:   10.668


× No keyword cloud information.
  16 in total

1.  Non-Vitamin K Antagonist Oral Anticoagulant Treatment in Centenarians: A Series of Four Cases.

Authors:  Yuval Kuntzman; Eyal Zimlichman; Howard Amital; Shmuel Tiosano
Journal:  Clin Drug Investig       Date:  2019-12       Impact factor: 2.859

2.  Emergency Physician Patterns Related to Anticoagulation of Patients with Recent-Onset Atrial Fibrillation and Flutter.

Authors:  Paraish Misra; Eddy Lang; Catherine M Clement; Robert J Brison; Brian H Rowe; Bjug Borgundvaag; Trevor Langhan; Kirk Magee; Rob Stenstrom; Jeffrey J Perry; David Birnie; George A Wells; X Xue; G Innes; Ian G Stiell
Journal:  J Atr Fibrillation       Date:  2013-04-06

3.  Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis.

Authors:  Lai-Chu See; Hsin-Fu Lee; Tze-Fan Chao; Pei-Ru Li; Jia-Rou Liu; Lung-Sheng Wu; Shang-Hung Chang; Yung-Hsin Yeh; Chi-Tai Kuo; Yi-Hsin Chan; Gregory Y H Lip
Journal:  Cardiovasc Drugs Ther       Date:  2020-11-19       Impact factor: 3.727

4.  Atrial fibrillation symptom clusters and associated clinical characteristics and outcomes: A cross-sectional secondary data analysis.

Authors:  Megan Streur; Sarah J Ratcliffe; David Callans; M Benjamin Shoemaker; Barbara Riegel
Journal:  Eur J Cardiovasc Nurs       Date:  2018-05-22       Impact factor: 3.908

5.  Bleeding risk with dabigatran, rivaroxaban, warfarin, and antiplatelet agent in Asians with non-valvular atrial fibrillation.

Authors:  Yi-Hsin Chan; Yung-Hsin Yeh; Hui-Tzu Tu; Chi-Tai Kuo; Shang-Hung Chang; Lung-Sheng Wu; Hsin-Fu Lee; Lai-Chu See
Journal:  Oncotarget       Date:  2017-10-24

6.  Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation.

Authors:  Yi-Hsin Chan; Lai-Chu See; Hui-Tzu Tu; Yung-Hsin Yeh; Shang-Hung Chang; Lung-Sheng Wu; Hsin-Fu Lee; Chun-Li Wang; Chang-Fu Kuo; Chi-Tai Kuo
Journal:  J Am Heart Assoc       Date:  2018-04-05       Impact factor: 5.501

7.  The comparison of non-vitamin K antagonist oral anticoagulants versus well-managed warfarin with a lower INR target of 1.5 to 2.5 in Asians patients with non-valvular atrial fibrillation.

Authors:  Yi-Hsin Chan; Kuang-Tso Lee; Yi-Wei Kao; Chien-Ying Huang; Yung-Lung Chen; Samuel Chi-Ling Hang; Pao-Hsien Chu
Journal:  PLoS One       Date:  2019-03-18       Impact factor: 3.240

8.  Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulant and Warfarin in Cirrhotic Patients With Nonvalvular Atrial Fibrillation.

Authors:  Hsin-Fu Lee; Yi-Hsin Chan; Shang-Hung Chang; Hui-Tzu Tu; Shao-Wei Chen; Yung-Hsin Yeh; Lung-Sheng Wu; Chang-Fu Kuo; Chi-Tai Kuo; Lai-Chu See
Journal:  J Am Heart Assoc       Date:  2019-03-05       Impact factor: 5.501

9.  Results from the Registry of Atrial Fibrillation (AFABE): Gap between Undiagnosed and Registered Atrial Fibrillation in Adults--Ineffectiveness of Oral Anticoagulation Treatment with VKA.

Authors:  Anna Panisello-Tafalla; Josep Lluís Clua-Espuny; Vicente F Gil-Guillen; Antonia González-Henares; María Lluisa Queralt-Tomas; Carlos López-Pablo; Jorgina Lucas-Noll; Iñigo Lechuga-Duran; Rosa Ripolles-Vicente; Jesús Carot-Domenech; Miquel Gallofré López
Journal:  Biomed Res Int       Date:  2015-07-01       Impact factor: 3.411

10.  A prospective multicenter observational study evaluating the risk of periendoscopic events in patients using anticoagulants: the Osaka GIANT Study.

Authors:  Takuya Inoue; Hideki Iijima; Takuya Yamada; Yuji Okuyama; Kanae Takahashi; Tsutomu Nishida; Ryu Ishihara; Tomofumi Akasaka; Ichizo Kobayashi; Toshio Kuroshima; Yuichi Yasunaga; Katsumi Yamamoto; Masanori Nakahara; Yoshinori Doi; Sachiko Nakajima; Akira Mukai; Eiji Masuda; Shunsuke Yoshii; Yoshito Hayashi; Hitoshi Minamiguchi; Yasushi Sakata; Kouji Yamamoto; Masahiko Tsujii; Tetsuo Takehara
Journal:  Endosc Int Open       Date:  2019-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.